World's Best Scientists 2026 revealed!
Expert Review of Hematology
H-index 20

Expert Review of Hematology

1747-4086

Published by: Taylor & Francis

https://www.tandfonline.com/toc/ierr20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1253 114 121 19

Additional Metrics

Number of Best Scientists*: 152
Documents by Best Scientists*: 153
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 58
SCIMAGO SJR: 0.724
Impact Factor: 2.1

Overview

Top Research Topics at Expert Review of Hematology?

Expert Review of Hematology was organized to reinforce research efforts on Internal medicine, Immunology, Oncology, Intensive care medicine and Disease. Expert Review of Hematology encompasses presentations on Internal medicine, specifically Multiple myeloma, Myeloid leukemia, Lymphoma, Transplantation and Clinical trial. It explores issues in Myeloid leukemia which can be linked to other research areas like Myeloid and Tyrosine kinase.

The study of Pathology serves as the foundation of the Lymphoma research discussed in it. The Transplantation works, particularly on Hematopoietic stem cell transplantation are tackled in Expert Review of Hematology. It concentrated on Immunology research, specifically Leukemia, Chronic lymphocytic leukemia, Platelet, Immune system and Immunotherapy.

Oncology research presented in it encompasses a variety of subjects, including Lenalidomide, Refractory, Chemotherapy, Minimal residual disease and Rituximab. The journal explores research in Intensive care medicine and the adjacent study of Surgery. Expert Review of Hematology facilitates discussions on Disease that incorporate concepts from other fields like Anemia and Pediatrics.

  • Internal medicine (37.82%)
  • Immunology (27.16%)
  • Oncology (26.90%)

What are the most cited papers published in the journal?

  • Allogeneic hematopoietic cell transplantation: the state of the art (121 citations)
  • Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. (120 citations)
  • Relapse after allogeneic stem cell transplantation (110 citations)

Research areas of the most cited articles at Expert Review of Hematology:

The main points discussed in the most cited papers deal with Immunology, Internal medicine, Disease, Oncology and Intensive care medicine. Issues in Immunology were discussed in the journal publications, taking into consideration concepts from other disciplines like Stem cell and Transplantation. The journal articles hold forums on Internal medicine that merge themes from other disciplines such as Gastroenterology and Surgery.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

Expert Review of Hematology investigates studies in Internal medicine, Oncology, Intensive care medicine, Multiple myeloma and Disease. The journal connects the study in Internal medicine with the closely related area of Gastroenterology. Topics in Oncology explored in it were investigated in conjunction with research in Chemotherapy, Refractory, Venetoclax, Myeloid leukemia and Transplantation.

Intensive care medicine research in it involves the investigation of Targeted therapy studies, all of which are linked to disciplines such as Interleukin-3 receptor and Malignancy. The research on Multiple myeloma tackled can also make contributions to studies in the areas of Newly diagnosed and Dexamethasone. The work on Disease tackled in it brings together disciplines like Pediatrics and Drug.

The most cited articles from the last journal are:

  • The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review. (6 citations)
  • Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors (4 citations)
  • Chronic lymphocytic leukemia prognostic models in real life: still a long way off. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Expert Review of Hematology (based on the number of publications) are:

  • Amer M. Zeidan (20 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • E. Carlos Rodríguez-Merchán (17 papers) absent at the last edition,
  • Meletios A. Dimopoulos (13 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Ali T. Taher (12 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Francis J. Giles (10 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Review of Hematology (based on the number of publications) are:

  • Harvard University (36 papers) published 3 papers at the last edition, 2 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (34 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Hospital Universitario La Paz (29 papers) published 6 papers at the last edition, 1 more than at the previous edition,
  • Mayo Clinic (28 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • National and Kapodistrian University of Athens (22 papers) published 4 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.20% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 23.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.82% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.91% of all publications and 53.41% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Challenges and Future Research Directions

One important section that seems to be missing from the article is discussion of the challenges that the field of hematology currently faces, as well as future directions for research. There is a need for a critical evaluation of the current status of hematology research and its limitations. Such a discourse can help both researchers and students to gain insight into the existing gaps and areas that hold promise for future exploration. Research in hematology is multifaceted and interconnected with numerous medical disciplines such as internal medicine, oncology, and transplantation among others. Therefore, isolating challenges and demarcating them within specific domains might be a meticulous task. However, some overarching issues in hematology research might include - lack of sufficient data on rare blood disorders, ethical considerations in stem cell research, and difficulties in translating lab-based findings to clinical applications.

Future research in the field of hematology is expected to have a profound impact on clinical applications and policy decision making. These may involve advancements in personalized medicine through genomics and proteomics, development of new therapeutic interventions, and exploring the role of immunotherapy in treating various types of cancer. Additionally, with the rise of technology, the integration of artificial intelligence in diagnosis and treatment of hematological diseases seem to provide a promising future horizon.

For students and professionals together venturing into the field of hematology or looking to transition into specialized roles, gaining a comprehensive knowledge about nurse practitioner program requirements georgia can be a beneficial starting point. Trends in research can often dictate the specific prerequisite studies and qualifications needed for a successful career in the related fields.

Conclusively, while challenges persist, the future of hematology research lies in the synthesis of multidisciplinary efforts and advancement of technology to improve clinical outcomes.

Top Publications

  • Immune thrombocytopenia

    (2021)
    79 Citations
  • Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia.

    Mackenzie Bloom;Jamie L Maciaszek;Mary Egan Clark;Ching-Hon Pui

    (2020)
    43 Citations
  • The role of regulatory T cells in graft-versus-host disease management.

    Jennifer S Whangbo;Joseph H Antin;John Koreth

    (2020)
    39 Citations
  • Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd.

    Ajai Chari;Paul G. Richardson;Dorothy Romanus;Meletios A. Dimopoulos

    (2020)
    36 Citations
  • Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?

    (2021)
    33 Citations
  • Management of age-associated medical complications in patients with β-thalassemia.

    Irene Motta;Irene Motta;Marta Mancarella;Alessia Marcon;Marco Vicenzi;Marco Vicenzi

    (2020)
    29 Citations
  • Management of immune thrombocytopenia in women: current standards and special considerations.

    Francesco Rodeghiero;Ettore Marranconi

    (2020)
    27 Citations
  • Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape.

    Roman M Shapiro;Joseph H Antin

    (2020)
    26 Citations
  • Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment

    Anne-Mette Hvas;Emmanuel J Favaloro;Maja Hellfritzsch

    (2021)
    23 Citations
  • Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases.

    Massimiliano Camilli;Giulia Iannaccone;Giulia La Vecchia;Luigi Cappannoli

    (2021)
    23 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their expertise in healthcare without enrolling in a full medical program, there are several valuable online degree options. A popular choice is pursuing a health administration degree online, which prepares students for leadership roles in hospitals and healthcare organizations. These programs often emphasize management skills alongside health policy and finance.

Cost is a major consideration when selecting an online program. Students seeking affordable options may explore the healthcare administration degree online programs that offer quality education without a heavy financial burden. These degrees serve as a stepping stone to healthcare management careers.

For those passionate about direct patient care, nursing pathways remain essential. The nursing degree online offers flexible routes to become a registered nurse (RN), a critical role within any healthcare system. Advancing further, many students consider cheapest online fnp programs to become Family Nurse Practitioners, who provide primary care and have greater autonomy in patient treatment.

Together, these related degrees provide diverse career pathways that complement or serve as alternatives to traditional medical degrees in the USA, offering flexibility and accessibility to reach healthcare goals.

Best Scientists Contributing to This Journal